Trade Allakos Inc. - ALLK CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026346% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.004124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Allakos Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
| Prev. Close* | 2.6 |
| Open* | 2.55 |
| 1-Year Change* | -69.28% |
| Day's Range* | 2.55 - 2.89 |
| 52 wk Range | 1.48-8.73 |
| Average Volume (10 days) | 617.07K |
| Average Volume (3 months) | 21.04M |
| Market Cap | 154.83M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 87.48M |
| Revenue | N/A |
| EPS | -1.93 |
| Dividend (Yield %) | N/A |
| Beta | 0.57 |
| Next Earnings Date | Mar 4, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 5, 2023 | 2.82 | 0.23 | 8.88% | 2.59 | 2.94 | 2.52 |
| Dec 4, 2023 | 2.60 | 0.25 | 10.64% | 2.35 | 2.62 | 2.35 |
| Dec 1, 2023 | 2.27 | 0.05 | 2.25% | 2.22 | 2.32 | 2.18 |
| Nov 30, 2023 | 2.21 | 0.05 | 2.31% | 2.16 | 2.32 | 2.16 |
| Nov 29, 2023 | 2.14 | 0.37 | 20.90% | 1.77 | 2.14 | 1.77 |
| Nov 28, 2023 | 1.79 | -0.03 | -1.65% | 1.82 | 1.82 | 1.70 |
| Nov 27, 2023 | 1.77 | 0.03 | 1.72% | 1.74 | 1.85 | 1.72 |
| Nov 24, 2023 | 1.79 | 0.06 | 3.47% | 1.73 | 1.83 | 1.71 |
| Nov 22, 2023 | 1.70 | -0.08 | -4.49% | 1.78 | 1.81 | 1.70 |
| Nov 21, 2023 | 1.75 | -0.12 | -6.42% | 1.87 | 1.87 | 1.74 |
| Nov 20, 2023 | 1.88 | 0.05 | 2.73% | 1.83 | 1.93 | 1.83 |
| Nov 17, 2023 | 1.86 | 0.08 | 4.49% | 1.78 | 1.89 | 1.74 |
| Nov 16, 2023 | 1.77 | -0.16 | -8.29% | 1.93 | 1.93 | 1.77 |
| Nov 15, 2023 | 1.95 | 0.15 | 8.33% | 1.80 | 2.03 | 1.79 |
| Nov 14, 2023 | 1.80 | 0.12 | 7.14% | 1.68 | 1.80 | 1.45 |
| Nov 13, 2023 | 1.78 | 0.03 | 1.71% | 1.75 | 1.80 | 1.68 |
| Nov 10, 2023 | 1.78 | 0.04 | 2.30% | 1.74 | 1.82 | 1.68 |
| Nov 9, 2023 | 1.72 | -0.10 | -5.49% | 1.82 | 1.83 | 1.69 |
| Nov 8, 2023 | 1.85 | -0.15 | -7.50% | 2.00 | 2.00 | 1.83 |
| Nov 7, 2023 | 2.04 | 0.05 | 2.51% | 1.99 | 2.06 | 1.94 |
Allakos Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| Monday, March 4, 2024 | ||
| Time (UTC) 10:59 | Country US
| Event Q4 2023 Allakos Inc Earnings Release Q4 2023 Allakos Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Total Operating Expense | 322.429 | 269.575 | 157.057 | 91.418 | 45.721 |
| Selling/General/Admin. Expenses, Total | 57.348 | 75.147 | 51.524 | 29.56 | 12.434 |
| Research & Development | 265.081 | 196.328 | 105.533 | 61.858 | 33.287 |
| Operating Income | -322.429 | -269.575 | -157.057 | -91.418 | -45.721 |
| Interest Income (Expense), Net Non-Operating | 3.673 | 0.377 | 4.313 | 6.201 | 2.375 |
| Other, Net | -1.196 | -0.662 | -0.736 | -0.155 | -0.192 |
| Net Income Before Taxes | -319.952 | -269.86 | -153.48 | -85.372 | -43.538 |
| Net Income After Taxes | -319.952 | -269.86 | -153.48 | -85.372 | -43.538 |
| Net Income Before Extra. Items | -319.952 | -269.86 | -153.48 | -85.372 | -43.538 |
| Net Income | -319.952 | -269.86 | -153.48 | -85.372 | -43.538 |
| Income Available to Common Excl. Extra. Items | -319.952 | -269.86 | -153.48 | -85.372 | -43.538 |
| Income Available to Common Incl. Extra. Items | -319.952 | -269.86 | -153.48 | -85.372 | -43.538 |
| Diluted Net Income | -319.952 | -269.86 | -153.48 | -85.372 | -43.538 |
| Diluted Weighted Average Shares | 63.284 | 53.832 | 49.492 | 45.191 | 43.102 |
| Diluted EPS Excluding Extraordinary Items | -5.05581 | -5.013 | -3.10111 | -1.88914 | -1.01012 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Diluted Normalized EPS | -5.05581 | -5.0483 | -3.10111 | -1.88914 | -1.01012 |
| Unusual Expense (Income) | -1.9 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Total Operating Expense | 37.817 | 45.046 | 46.216 | 31.445 | 49.117 |
| Selling/General/Admin. Expenses, Total | 10.537 | 11.968 | 10.828 | 13.007 | 14.669 |
| Research & Development | 27.28 | 33.078 | 35.388 | 18.438 | 34.448 |
| Operating Income | -37.817 | -45.046 | -46.216 | -31.445 | -49.117 |
| Interest Income (Expense), Net Non-Operating | 2.697 | 2.678 | 2.775 | 0.711 | 0.104 |
| Other, Net | 0 | -0.036 | 0.452 | -0.103 | -0.09 |
| Net Income Before Taxes | -35.12 | -42.404 | -42.989 | -30.837 | -49.103 |
| Net Income After Taxes | -35.12 | -42.404 | -42.989 | -30.837 | -49.103 |
| Net Income Before Extra. Items | -35.12 | -42.404 | -42.989 | -30.837 | -49.103 |
| Net Income | -35.12 | -42.404 | -42.989 | -30.837 | -49.103 |
| Income Available to Common Excl. Extra. Items | -35.12 | -42.404 | -42.989 | -30.837 | -49.103 |
| Income Available to Common Incl. Extra. Items | -35.12 | -42.404 | -42.989 | -30.837 | -49.103 |
| Diluted Net Income | -35.12 | -42.404 | -42.989 | -30.837 | -49.103 |
| Diluted Weighted Average Shares | 86.646 | 85.845 | 85.421 | 58.169 | 54.798 |
| Diluted EPS Excluding Extraordinary Items | -0.40533 | -0.49396 | -0.50326 | -0.53013 | -0.89607 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.40533 | -0.49396 | -0.50326 | -0.53013 | -0.89607 |
| Unusual Expense (Income) |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 308.843 | 451.581 | 669.267 | 499.87 | 181.609 |
| Cash and Short Term Investments | 279.786 | 424.238 | 658.997 | 495.901 | 178.906 |
| Cash & Equivalents | 87.217 | 152.822 | 207.177 | 38.367 | 33.66 |
| Prepaid Expenses | 29.057 | 27.343 | 10.27 | 3.969 | 2.703 |
| Total Assets | 386.42 | 534.824 | 719.618 | 516.894 | 191.259 |
| Property/Plant/Equipment, Total - Net | 69.369 | 74.807 | 48.076 | 14.185 | 8.848 |
| Property/Plant/Equipment, Total - Gross | 77.636 | 80.615 | 51.657 | 16.221 | 9.483 |
| Accumulated Depreciation, Total | -8.267 | -5.808 | -3.581 | -2.036 | -0.635 |
| Other Long Term Assets, Total | 8.208 | 8.436 | 2.275 | 2.839 | 0.802 |
| Total Current Liabilities | 30.038 | 40.249 | 22.45 | 13.061 | 5.256 |
| Accounts Payable | 4.832 | 13.692 | 13.96 | 5.963 | 2.092 |
| Accrued Expenses | 24.15 | 21.703 | 8.403 | 7.008 | 3.005 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 1.056 | 4.854 | 0.087 | 0.09 | 0.159 |
| Total Liabilities | 75.987 | 89.348 | 65.223 | 21.173 | 7.265 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | |||||
| Other Liabilities, Total | 45.949 | 49.099 | 42.773 | 8.112 | 2.009 |
| Total Equity | 310.433 | 445.476 | 654.395 | 495.721 | 183.994 |
| Redeemable Preferred Stock | 0 | 0 | 0 | ||
| Common Stock | 0.085 | 0.054 | 0.053 | 0.048 | 0.042 |
| Additional Paid-In Capital | 1243.41 | 1058.4 | 997.298 | 685.02 | 288.079 |
| Retained Earnings (Accumulated Deficit) | -932.776 | -612.824 | -342.964 | -189.484 | -104.112 |
| Total Liabilities & Shareholders’ Equity | 386.42 | 534.824 | 719.618 | 516.894 | 191.259 |
| Total Common Shares Outstanding | 85.387 | 54.622 | 53.081 | 48.668 | 42.117 |
| Short Term Investments | 192.569 | 271.416 | 451.82 | 457.534 | 145.246 |
| Preferred Stock - Non Redeemable, Net | 0 | ||||
| Other Equity, Total | -0.284 | -0.153 | 0.008 | 0.137 | -0.015 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 218.279 | 251.562 | 282.86 | 308.843 | 339.202 |
| Cash and Short Term Investments | 193.908 | 221.102 | 252.599 | 279.786 | 325.32 |
| Cash & Equivalents | 70.519 | 67.381 | 93.854 | 87.217 | 205.29 |
| Short Term Investments | 123.389 | 153.721 | 158.745 | 192.569 | 120.03 |
| Prepaid Expenses | 24.371 | 30.46 | 30.261 | 29.057 | 13.882 |
| Total Assets | 283.495 | 319.196 | 350.408 | 386.42 | 418.566 |
| Property/Plant/Equipment, Total - Net | 59.132 | 60.935 | 62.567 | 69.369 | 70.679 |
| Property/Plant/Equipment, Total - Gross | 71.992 | 72.245 | 72.356 | 77.636 | 77.433 |
| Accumulated Depreciation, Total | -12.86 | -11.31 | -9.789 | -8.267 | -6.754 |
| Other Long Term Assets, Total | 6.084 | 6.699 | 4.981 | 8.208 | 8.685 |
| Total Current Liabilities | 23.45 | 24.484 | 29.53 | 30.038 | 27.588 |
| Accounts Payable | 0.915 | 4.307 | 9.101 | 4.832 | 4.616 |
| Accrued Expenses | 21.933 | 19.25 | 18.258 | 24.15 | 19.926 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.602 | 0.927 | 2.171 | 1.056 | 3.046 |
| Total Liabilities | 62.452 | 64.218 | 69.96 | 75.987 | 74.387 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 39.002 | 39.734 | 40.43 | 45.949 | 46.799 |
| Total Equity | 221.043 | 254.978 | 280.448 | 310.433 | 344.179 |
| Redeemable Preferred Stock | |||||
| Common Stock | 0.087 | 0.087 | 0.086 | 0.085 | 0.085 |
| Additional Paid-In Capital | 1276.95 | 1265.35 | 1255.53 | 1243.41 | 1233.94 |
| Retained Earnings (Accumulated Deficit) | -1055.93 | -1010.3 | -975.18 | -932.776 | -889.787 |
| Other Equity, Total | -0.072 | -0.159 | 0.012 | -0.284 | -0.064 |
| Total Liabilities & Shareholders’ Equity | 283.495 | 319.196 | 350.408 | 386.42 | 418.566 |
| Total Common Shares Outstanding | 87.476 | 86.823 | 86.56 | 85.387 | 85.193 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -319.952 | -269.86 | -153.48 | -85.372 | -43.538 |
| Cash From Operating Activities | -279.971 | -207.853 | -113.924 | -63.012 | -38.45 |
| Cash From Operating Activities | 7.071 | 2.31 | 1.545 | 1.508 | 0.242 |
| Deferred Taxes | 0 | 0 | |||
| Non-Cash Items | 46.678 | 54.974 | 36.598 | 13.375 | 3.178 |
| Cash Interest Paid | 0 | 0 | |||
| Changes in Working Capital | -13.768 | 4.723 | 1.413 | 7.477 | 1.668 |
| Cash From Investing Activities | 71.681 | 143.238 | 3.897 | -311.971 | -151.047 |
| Capital Expenditures | -8.333 | -33.221 | -0.63 | -0.77 | -6.946 |
| Cash From Financing Activities | 141.882 | 10.26 | 278.837 | 381.163 | 138.752 |
| Financing Cash Flow Items | 0 | 0 | |||
| Issuance (Retirement) of Stock, Net | 141.882 | 10.26 | 278.837 | 381.163 | 138.702 |
| Issuance (Retirement) of Debt, Net | 0 | 0 | 0.05 | ||
| Net Change in Cash | -66.408 | -54.355 | 168.81 | 6.18 | -50.745 |
| Other Investing Cash Flow Items, Total | 80.014 | 176.459 | 4.527 | -311.201 | -144.101 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -42.404 | -319.952 | -276.963 | -246.126 | -197.023 |
| Cash From Operating Activities | -30.139 | -279.971 | -233.185 | -207.057 | -174.287 |
| Cash From Operating Activities | 1.524 | 7.071 | 5.56 | 4.064 | 2.123 |
| Non-Cash Items | 9.665 | 46.678 | 38.707 | 25.758 | 12.935 |
| Changes in Working Capital | 1.076 | -13.768 | -0.489 | 9.247 | 7.678 |
| Cash From Investing Activities | 35.318 | 71.681 | 143.158 | 135.471 | 57.412 |
| Capital Expenditures | -0.267 | -8.333 | -8.042 | -5.699 | -2.589 |
| Other Investing Cash Flow Items, Total | 35.585 | 80.014 | 151.2 | 141.17 | 60.001 |
| Cash From Financing Activities | 1.458 | 141.882 | 141.692 | 0.413 | 0.347 |
| Issuance (Retirement) of Stock, Net | 1.458 | 141.882 | 141.692 | 0.413 | 0.347 |
| Net Change in Cash | 6.637 | -66.408 | 51.665 | -71.173 | -116.528 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| BVF Partners L.P. | Hedge Fund | 9.9547 | 8652417 | 2592170 | 2023-06-30 | LOW |
| New Enterprise Associates (NEA) | Venture Capital | 7.0725 | 6147260 | 0 | 2023-06-30 | LOW |
| Logos Global Management LLC | Investment Advisor | 6.0402 | 5250000 | -286666 | 2023-06-30 | HIGH |
| RiverVest Venture Partners, LLC | Venture Capital | 5.7382 | 4987522 | 99590 | 2023-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.614 | 4879553 | 3005110 | 2023-06-30 | LOW |
| Citadel Advisors LLC | Hedge Fund | 5.4844 | 4766929 | 1835833 | 2023-10-13 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.0341 | 4375518 | 548316 | 2023-06-30 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 4.3938 | 3818970 | 2637956 | 2023-06-30 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.7179 | 3231528 | 291878 | 2023-06-30 | LOW |
| Vivo Capital, LLC | Venture Capital | 3.4377 | 2988000 | -1132134 | 2023-06-30 | LOW |
| Alta Partners | Venture Capital | 2.9294 | 2546147 | -6504346 | 2023-08-18 | LOW |
| Redmile Group, LLC | Investment Advisor/Hedge Fund | 2.6273 | 2283594 | -2583 | 2023-06-30 | LOW |
| Blackstone Alternative Asset Management, L.P. | Investment Advisor/Hedge Fund | 2.2908 | 1991115 | 1991115 | 2023-06-30 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6335 | 1419803 | 664221 | 2023-06-30 | LOW |
| Millennium Management LLC | Hedge Fund | 1.4251 | 1238703 | 343338 | 2023-06-30 | HIGH |
| Ikarian Capital LLC | Hedge Fund | 0.8883 | 772092 | 772092 | 2023-06-30 | HIGH |
| Bank Vontobel AG | Research Firm | 0.886 | 770132 | 335822 | 2023-09-30 | MED |
| EcoR1 Capital, LLC | Hedge Fund | 0.8616 | 748900 | 748900 | 2023-06-30 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.8409 | 730911 | 43537 | 2023-06-30 | HIGH |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.8086 | 702854 | 145681 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Allakos Inc. Company profile
About Allakos Inc
Allakos Inc. is a clinical stage biotechnology company. The Company is developing therapeutics, which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory, and proliferative diseases. Its advanced antibodies are lirentelimab (AK002) and AK006. AK002 selectively targets both mast cells and eosinophils, two types of white blood cells that are widely distributed in the body and play a central role in the inflammatory response. It is developing AK002 for the treatment of eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic duodenitis (EoD), atopic dermatitis, chronic spontaneous urticaria and additional indications. AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. It also developed a formulation of lirentelimab for subcutaneous (SC) administration. The Company is also developing additional antibodies targeting inhibitory receptors expressed on key disease-driving immune cells.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Allakos Inc revenues was not reported. Net loss increased 76% to $269.9M. Higher net loss reflects Research and Development - Balancing increase of 88% to $176.5M (expense), General and Administrative - Balancing increase of 49% to $44.2M (expense), Stock-based Compensation in SGA increase of 42% to $31M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$3.10 to -$5.01.
| Industry: | Bio Therapeutic Drugs |
825 Industrial Road
Suite 500
SAN CARLOS
CALIFORNIA 94070
US
Income Statement
- Annual
- Quarterly
News
December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com